Topiramate
Product Images NDC 42549-621

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 42549-621). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image 100 mg (Topiramate 100 mg Label 42549)

Label Image 100 mg (Topiramate 100 mg Label 42549)
This is a drug label information. The drug is called "Topira" and it comes in tablet form. Each tablet contains 100mg of the drug. The manufacturer of the drug is "Carace Pharm. Labs,, Lid". The NDC (National Drug Code) for the drug is 42549-621-60. The lot number for the sample mentioned is 673180. The expiry date mentioned on the sample is 05/13 and it was sampled on 12/2/2011.*
FDA Label Image

Label Image 25 mg (Topiramate 25 mg Label 42549)

Label Image 25 mg (Topiramate 25 mg Label  42549)
This is a description of a medicine containing 25mg of Topiramale, packaged and distributed in Gainesville. The distributor is Caaco Pharm, Labs, L4. The NDC number is 42549-619-60 and the Lot number is not readable. The medicine may cause drowsiness or dizziness.*
FDA Label Image

Label Image 50 mg (Topiramate 50 mg Label 42549)

Label Image 50 mg (Topiramate 50 mg Label 42549)
This is a prescription medicine called Topiramate, USP which comes in tablet form with a strength of 50mg. It is distributed by Caraco Pharm Labs for treatment of various medical conditions. No additional information is available.*
FDA Label Image

Topiramate-structure (Topiramate 1)

FDA Label Image

Topiramate-fig01 (Topiramate 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.